Abstract
Pharmaceutical marketing has become ubiquitous in today's society. Acquisition of nonbiased, evidence-based information on drugs is essential for prescribers and is a key component of continuing professional development in the health professions. However, the process by which prescribers obtain information on drugs has come under increasing scrutiny over the past decade as institutional and legislative entities have questioned the propriety of health profession education that is funded by the pharmaceutical industry. This article provides important policy perspectives for this timely debate for nurse practitioners.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
